| 1/22 | US=59-B / Câncer Snitcovsky I, Brentani MM. Fatores de crescimento. In: Brentani MM, Coelho FRG, Kowalski LP. Bases da oncologia. 2ªed. São Paulo: Lemar, 2003. p. 167-76. FATORES DE CRESCIMENTO. RECEPTORES; NEOPLASIA; RECEPTORES TRUNCADOS; ALVOS MOLECULARES |
| 2/22 | US=70 / Câncer Santos EMM. Terapia genética II: aplicações no tratamento do câncer. In: Santos EMM, Rossi BM. Câncer hereditário: atualização. São Paulo: Lemar, 2006. p. 151-3. ESTUDOS TERAPIA GENETICA; ALVOS MOLECULARES; ALVOS IMUNOLOGICOS |
| 3/22 | US=2 / Ginecologia Muggia F, Gold LI, Curtin J. Future directions: new targets. In: Muggia F, Oliva E. Uterine cancer: screening, diagnosis, and treatment. New York: Humana Press, 2009. p. 267-83. ISBN 978-1-588-29-736-5. ALVOS MOLECULARES; IMUNOTERAPIA; PTEN; MTOR; HORMONIO; RECEPTORES |
| 4/22 | US=60 / Biol/Mol Balcer-Kubiczek EK, Garofalo MC. Molecular targets in gastric cancer and apoptosis. In: Chen GG, Lai PBS. Apoptosis in carcinogenesis and chemotherapy: apoptosis in cancer. New York: Springer, 2009. p. 157-92. ISBN 978-1-4020-9596-2. APOPTOSE; MORTE CELULAR PROGRAMADA; ALVOS MOLECULARES; CANCER GASTRICO; REGULADORES DO CANCER; MICRORNA; CELULAS-TRONCO; CANCER GASTRICO. EPIDEMIOLOGIA; CANCER GASTRICO. CLASSIFICACAO PATOLOGICA; CANCER GASTRICO. TRATAMENTO; CANCER GASTRICO. ASPECTOS MOLECULARES; VIAS APOPTOTICAS |
| 5/22 | US=110 / Câncer Murgo AJ, Kummar S, Gutierrez M, Tomaszewski JE, Doroshow JH. Principles of molecularly targeted therapy: present and future. In: Abeloff MD. Abeloff's clinical oncology. 4th ed. Philadelphia: Churchill Livingstone, 2008. p. 485-500. ISBN 978-0-443-06695-5. CANCER; TERAPIA ALVO MOLECULAR; ALVOS MOLECULARES; AGENTES ANTICANCERIGENOS; IMAGEM FUNCIONAL; IMAGEM MOLECULAR; SELECAO DO PACIENTE |
| 6/22 | US=13 / Biol/Mol Pecorino L. Introduction. In: ___. Molecular biology of cancer: mechanisms, targets, and therapeutics. 2nd ed. Oxford: Oxford University Press, 2008. p. 1-19. ISBN 978-0-19-921148-7. CANCER. DEFINICAO; CARACTERISTICAS DO CANCER; CRESCIMENTO CELULAR; APOPTOSE; ONCOGENE; GENES SUPRESSORES DE TUMOR; CARCINOGENESE; FATORES DE RISCO; CANCER. TERAPIA; ENSAIOS CLINICOS; ALVOS MOLECULARES |
| 7/22 | US=35 / Biol/Mol Neckers L. Heat shock protein 90 and the proteasome: housekeeping proteins become novel molecular targets for cancer therapy. In: Mendelsohn J, Howley PM, Israel MA,Gray JW, Thompson CB. The molecular basis of cancer. 3rd ed. Philadelphia: Saunders Elsevier, 2008. p. 701-10. ISBN 978-1-4160-3703-3. PROTEINA DE CHOQUE TERMICO 90; PROTEASSOMA; ALVOS MOLECULARES; CANCER. TERAPIA; HSP90 |
| 8/22 | US=67 / Biol/Mol Azad NS, Sarosy G, Kohn EC. Molecular targets in ovarian cancer and endometrial cancer. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 291-308. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. CANCER DE OVARIO; CANCER ENDOMETRIAL; ALVOS MOLECULARES; TIROSINA-QUINASES; EGFR; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FATOR DE CRESCIMENTO VASCULAR ENDOTELIAL (VEGF); ONCOGENE; GENES SUPRESSORES DE TUMOR |
| 9/22 | US=67 / Biol/Mol Tomaszewski JE, Doroshow JH. Preclinical development of molecularly targeted agents in oncology. In: Kaufman HL, Wadler S, Antman K. Molecular targeting in oncology. New Jersey: Humana Press, 2008. p. 707-22. (Cancer Drug Discovery and Development) ISBN 978-1-58829-577-4. ONCOLOGIA; DESENVOLVIMENTO PRE-CLINICO; AGENTES ALVO MOLECULARES; AGENTES ANTITUMORAIS; DESENVOLVIMENTO DE DROGAS; ALVOS MOLECULARES; FARMACOCINETICA; FARMACODINAMICA; TOXICOLOGIA |
| 10/22 | US=69 / Câncer Welsh SJ, Powis G. Toward personalized therapy for cancer. In: Kurzrock R, Markman M. Targeted Cancer therapy. 2nd. New Jersey: Humana Press, 2008. p. 411-25. ISBN 978-1-60327-423-4. TERAPIA PERSONALIZADA PARA O CANCER; CANCER; MEDICINA PERSONALIZADA; TERAPIA INDIVIDUALIZADA; FARMACOGENOMICA; TERAPIA-ALVO; ALVOS MOLECULARES |
| 11/22 | US=111 / Câncer Doody LA, Sigman CC, Kelloff GJ. Intervention and chemoprevention of cancer - treatment of carcinogenesis. In: Alison MR. The cancer handbook. 2nd ed. New Jersey: John Wiley & Sons, 2007. p. 453-73. ISBN 978-0-470-01852-1. CANCER; INTERVENCAO; QUIMIOPREVENCAO; TRATAMENTO DA CARCINOGENESE; ALVOS MOLECULARES; QUIMIOPREVENTIVOS; DESCOBERTA DE DROGAS; DESENVOLVIMENTO PRECOCE |
| 12/22 | US=77-J / Câncer de Piorri R, Ong TP, Moreno FS. Quimioprevenção do câncer. In: Lopes A, Chammas R, Iyeyasu H. Oncologia para a graduação. 3ª ed. São Paulo: Lemar, 2013. p. 202-8. ISBN 8-5866523-7-0. CANCER; QUIMIOPREVENCAO; AGENTES QUIMIOPREVENTIVOS; MODULADORES SELETIVOS DO RECEPTOR DE ESTROGENO; FINASTERIDA; INIBIDORES SELETIVOS DA CICLOOXIGENASE 2; ALVOS MOLECULARES; ALVOS EPIGENETICOS |
| 13/22 | US=2-A / Biol/Mol Fischer U, Schulze-Osthoff K. Molecular targets and therapeutics: current therapeutic strategies targeting caspases in disease. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 862-90. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; ESTRATEGIAS TERAPEUTICAS; CASPASES; CATALISADORES DE MORTE; RESPOSTAS IMUNE INATA; BIOQUIMICA DE CASPASES |
| 14/22 | US=2-A / Biol/Mol Stridh H, Bykov VJN, Selivanova G, Wiman KG. Molecular targets and therapeutics: cancer therapy by reactivation of the p53 apoptosis pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 891-912. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; CANCER. TERAPIA; REATIVACAO DA APOPTOSE; VIA P53; TERAPIA GENETICA |
| 15/22 | US=2-A / Biol/Mol Armstrong RC, Belli BA, Deckwerth TL. Molecular targets and therapeutics: small-molecular inhibitors of the of apoptosis proteins. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 913-32. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DA PEQUENA MOLECULARES DE PROTEINAS; APOPTOSE |
| 16/22 | US=2-A / Biol/Mol Clarke PA, Powers M, Workman P. Molecular targets and therapeutics: inhibition of the molecular chaperone heat shock protein 90 in cancer: consequences for the regulation of survival signaling and induction of cell death. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 933-65. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBICAO DA CHAPERONE; CHOQUE TERMICO 90; CANCER; REGULACAO DA SINALIZACAO; SOBREVIVENCIA; INDUCAO DE MORTE CELULAR; PROTEINA HSP90 |
| 17/22 | US=2-A / Biol/Mol Graville CA, Memmott RM, Gills JJ, Dennis PA. Molecular targets and therapeutics: targeting the phosphoinositide-3-kinase/Akt/mammalian target of rapamycin pathway. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 966-96. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; RAPAMICINA; FOSFOINOSITIDE-3-QUINASE; AKT; P13K/AKT |
| 18/22 | US=2-A / Biol/Mol Kullmann S, Teichgräber V, Bollinger CR, Gulbins E. Molecular targets and therapeutics: ceramide signaling in apoptosis and cancer therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 997-1013. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; SINALIZACAO DE CERAMIDA; APOPTOSE; CANCER. TERAPIA |
| 19/22 | US=2-A / Biol/Mol Marks PA. Molecular targets and therapeutics: histone deacetylase inhibitors: development as anticancer agents. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1014-32. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; INIBIDORES DE HISTONA DEACETILASE; AGENTES ANTICANCER; ESTRUTURA DA CROMATINA; HDAC; ENSAIOS CLINICOS |
| 20/22 | US=2-A / Biol/Mol Rieger J, Weller M. Molecular targets and therapeutics: exploiting apoptosis pathways for glioblastoma therapy. In: Debatin K-M, Fulda S. Apoptosis and cancer therapy: from cutting-edge science to novel therapeutic concepts. Weinheim: Wiley-VCH, 2006. p. 1033-48. ISBN 978-3-527-31237-5. ALVOS MOLECULARES; TERAPEUTICA MOLECULAR; VIAS DE APOPTOSE; GLIOBLASTOMA. TERAPIA; PROTEINA P53; FAMILIA BCL-2; FATOR DE CRESCIMENTO DERIVADO DE PLAQUETAS; RECEPTOR DE FATOR DE CRESCIMENTO EPIDERMICO; FOSFOINOSITIDE-3-KINASE |